PRME

Prime Medicine (PRME)

About Prime Medicine (PRME)

Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.

Details

Daily high
$4.08
Daily low
$3.58
Price at open
--
52 Week High
$6.94
52 Week Low
$1.11
Market cap
651.6M
Dividend yield
0.00%
Volume
41
Avg. volume
4.0M
P/E ratio
-2.45

Prime Medicine News

Details

Daily high
$4.08
Daily low
$3.58
Price at open
--
52 Week High
$6.94
52 Week Low
$1.11
Market cap
651.6M
Dividend yield
0.00%
Volume
41
Avg. volume
4.0M
P/E ratio
-2.45